Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of DWJ1439 and DWJ1464 vs Reference UDCA in Healthy Volunteers
NCT04477369Phase 1Unknown
- Sponsor
- Daewoong Pharmaceutical
- Start
- Aug 2020
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ursodeoxycholic acid in primary biliary cholangitis (PBC) and cholelithiasis (4 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Area Under the Curve from Time 0 to Last Quantifiable Concentration and Maximum Plasma Concentration. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
primary biliary cholangitis (PBC)cholelithiasis
Beyond the preview
Go deeper on NCT04477369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04477369.